What's new

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 29, Status: Authorised

Apr 23, 2025 - 13:43
 0
Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

German cancer antibody biotech eyes SPAC as route to Nasdaq

Next Article

Opportunity, sustainability and innovation – the buzz around European dairy chal...

Related Posts

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Fields and business rules for the European Shortages Mo...

Mar 27, 2025  0

Start of procedure: Type II variation - extension of in...

Apr 1, 2025  0